US Stock MarketDetailed Quotes
ICCC ImmuCell
- 5.477
- +0.207+3.92%
Close May 14 16:00 ET
- 5.477
- 0.0000.00%
Post 18:45 ET
42.85MMarket Cap-7302P/E (TTM)
5.500High5.260Low9.20KVolume5.260Open5.270Pre Close50.38KTurnover0.16%Turnover RatioLossP/E (Static)7.82MShares6.05052wk High1.71P/B31.19MFloat Cap4.34052wk Low--Dividend TTM5.70MShs Float13.200Historical High--Div YieldTTM4.55%Amplitude1.000Historical Low5.477Avg Price1Lot Size
About ImmuCell Company
ImmuCell Corp. engages in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kits, and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME.
Company Profile
SymbolICCC
Company NameImmuCell
Listing DateApr 1, 1987
Issue Price7.00
Founded1982
CEOMr. Michael F. Brigham
MarketNASDAQ
Employees79
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address56 Evergreen Drive
CityPortland
ProvinceMaine
CountryUnited States of America
Zip Code04103
Phone1-207-878-2770
Websitehttp://www.immucell.com
Company Executives
- Name
- Position
- Salary
- Michael F. Brigham
- President, Chief Executive Officer, Treasurer, Secretary, Principal Financial Officer and Director
- 395.24K
- Bobbi Jo Brockmann
- Director and Vice President, Sales and Marketing
- 323.52K
- Elizabeth Luttrell Williams
- Vice President, Manufacturing Operations
- 312.07K
- Dr. David S. Tohe, D.V.M.
- Chairman of the Board
- 42.00K
- Gloria J. Basse
- Independent Director
- 28.00K
- Steven T. Rosgen
- Independent Director
- 30.00K
- Paul R. Wainman
- Independent Director
- 30.00K
- Bryan K. Gathagan
- Independent Director
- 51.30K
- Elizabeth S. Toothaker
- Controller
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg